Tilton John

Chief Commercial Officer at Biohaven Pharmaceutical Holding Co Ltd.

Sold, on record
$5.3M
Dollars the filings state
Form 4 sales
4
Latest Jun 10, 2020
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Nov 1, 2017 2017

    Sold 30,000 shares at $29.25 ($878k)

    Tilton John, Chief Commercial Officer

    Sold 100% of holdings ($878k position)0 shares leftFirst sale on recordFiling

  2. Jan 10, 2019 +435 days

    Sold 10,500 shares at $37.67 ($396k)

    Tilton John, Chief Commercial Officer

    Sold 100% of holdings ($396k position)0 shares leftFiling

  3. Mar 12, 2019 +61 days

    Sold 10,000 shares at $50.11 ($501k)

    Tilton John, Chief Commercial Officer

    Sold 100% of holdings ($501k position)0 shares leftFiling

  4. Jun 10, 2020 +456 days

    Sold 52,000 shares at $67.38 ($3.5M)

    Tilton John, Chief Commercial Officer

    Sold 98.5% of holdings ($3.6M position)770 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Tilton John
Source
Jun 10, 2020Jun 12, 2020Biohaven Pharmaceutical Holding Co Ltd.Chief Commercial OfficerForm 4 sale52,000$3.5M98.5%UnusualSEC
Mar 12, 2019Mar 14, 2019Biohaven Pharmaceutical Holding Co Ltd.Chief Commercial OfficerForm 4 sale10,000$501k100.0%UnusualSEC
Jan 10, 2019Jan 14, 2019Biohaven Pharmaceutical Holding Co Ltd.Chief Commercial OfficerForm 4 sale10,500$396k100.0%UnusualSEC
Nov 1, 2017Nov 2, 2017Biohaven Pharmaceutical Holding Co Ltd.Chief Commercial OfficerForm 4 sale30,000$878k100.0%UnusualSEC